Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind FarmaceutifiledCriticalSigma Tau Ind Farmaceuti
Application grantedgrantedCritical
Publication of TW377341BpublicationCriticalpatent/TW377341B/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
The present invention relates to process for manufacturing L-(-)-carnitine from D-(+)-carnitine or a derivative thereof. D-(+)-carnitine is esterified in order to protect the carboxyl group and subsequently converted to an acyl derivative. The acyl derivative is then converted to a lactone of L-(-)-carnitine. Finally, the lactone is reopened to obtain L-(-)-carnitine.
TW082110616A1992-12-211993-12-13Process for manufacturing L-(-)-carnitine from a waste product having opposite configuration
TW377341B
(en)